Cara Therapeutics, Inc. (CARA)
收市後：
| 前收市價 | 0.2935 |
| 開市 | 0.2800 |
| 買盤 | 0.1974 x 200 |
| 賣出價 | 0.3555 x 200 |
| 今日波幅 | 0.2700 - 0.2954 |
| 52 週波幅 | 0.2400 - 2.4800 |
| 成交量 | |
| 平均成交量 | 868,948 |
| 市值 | 14.82M |
| Beta 值 (5 年，每月) | 0.70 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.0400 |
| 業績公佈日 | 2024年11月11日 - 2024年11月15日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 1.00 |
ZacksCara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
Cara (CARA) delivered earnings and revenue surprises of -47.37% and 5.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
InvestorPlace7 F-Rated Stocks to Sell in March 2024
Are you feeling good about the stock market? You should. The market continued to show strength in early 2024, which is all the more reason to rid your portfolio of F-rated stocks. When the stock market’s this strong, it’s no time to consolidate your positions around bottom-dwellers at bargain prices. This is a time to capitalize on the market’s momentum and look for stocks that are already strong. So far in 2024, the Dow Jones Industrial Average is up more than 2%, topping 38,000. The Nasdaq Com
Insider MonkeyCara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript March 4, 2024 Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.57. CARA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]
